Organization and Liquidity (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended						9 Months Ended
	Aug. 12, 2016	Jan. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Jan. 11, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net income loss				$ 1,792,754	$ 2,184,372	$ 975,097	$ 998,425	$ 597,275	$ 681,839	$ 4,952,223	$ 2,277,539
Proceeds from issuance or sale of equity			$ 10,022,193
Exercisable price per share		$ 2.35
Securities Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Exercisable price per share												$ 2.35
Institutional Investor [Member] | Securities Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt instrument, face amount		$ 4,300,000
Net proceeds from warrants		$ 3,590,000
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Conversion of stock, shares issued	45,000,000
Sale of stock, percentage of ownership after transaction	100.00%
Net income loss
Common Stock [Member] | Institutional Investor [Member] | Securities Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Four year warrant to purchase		1,018,079
Exercisable price per share		$ 2.35